228 related articles for article (PubMed ID: 24895326)
1. The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma?
Dhayat SA; Mardin WA; Köhler G; Bahde R; Vowinkel T; Wolters H; Senninger N; Haier J; Mees ST
J Surg Oncol; 2014 Sep; 110(4):430-8. PubMed ID: 24895326
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
Dhayat SA; Hüsing A; Senninger N; Schmidt HH; Haier J; Wolters H; Kabar I
PLoS One; 2015; 10(10):e0140066. PubMed ID: 26447841
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers.
Hung CS; Liu HH; Liu JJ; Yeh CT; Chang TC; Wu CH; Ho YS; Wei PL; Chang YJ
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S360-8. PubMed ID: 22868917
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200a inhibits epithelial-mesenchymal transition in human hepatocellular carcinoma cell line.
Zhong C; Li MY; Chen ZY; Cheng HK; Hu ML; Ruan YL; Guo RP
Int J Clin Exp Pathol; 2015; 8(9):9922-31. PubMed ID: 26617701
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
[TBL] [Abstract][Full Text] [Related]
8. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
[TBL] [Abstract][Full Text] [Related]
9. [Gli1 expression and its relationship with the expression of Shh, Vimentin and E-cadherin in human hepatocellular carcinoma].
Xu QR; Zheng X; Zan XF; Yao YM; Yang W; Liu QG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 May; 28(5):536-9. PubMed ID: 22558994
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells.
Wang J; Yang X; Ruan B; Dai B; Gao Y; Duan J; Qu S; Tao K; Dou K; Li H
Tumour Biol; 2015 Apr; 36(4):2447-56. PubMed ID: 25412960
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition.
Zhou Y; Li Y; Ye J; Jiang R; Yan H; Yang X; Liu Q; Zhang J
Liver Int; 2013 Sep; 33(8):1271-80. PubMed ID: 23725476
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs associated with increased AKT gene number in human lung carcinoma.
Goto A; Dobashi Y; Tsubochi H; Maeda D; Ooi A
Hum Pathol; 2016 Oct; 56():1-10. PubMed ID: 27189341
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
[TBL] [Abstract][Full Text] [Related]
14. Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.
Yang YM; Lee WH; Lee CG; An J; Kim ES; Kim SH; Lee SK; Lee CH; Dhanasekaran DN; Moon A; Hwang S; Lee SJ; Park JW; Kim KM; Kim SG
Oncogene; 2015 May; 34(22):2910-21. PubMed ID: 25065598
[TBL] [Abstract][Full Text] [Related]
15. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
[TBL] [Abstract][Full Text] [Related]
16. MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis.
Wong CM; Wei L; Au SL; Fan DN; Zhou Y; Tsang FH; Law CT; Lee JM; He X; Shi J; Wong CC; Ng IO
Oncotarget; 2015 May; 6(15):13658-70. PubMed ID: 25909223
[TBL] [Abstract][Full Text] [Related]
17. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
Xu Q; Cai W; Zhang M; Liu Q; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
[TBL] [Abstract][Full Text] [Related]
18. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.
Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF
Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032
[TBL] [Abstract][Full Text] [Related]
19. miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer.
Brockhausen J; Tay SS; Grzelak CA; Bertolino P; Bowen DG; d'Avigdor WM; Teoh N; Pok S; Shackel N; Gamble JR; Vadas M; McCaughan GW
Liver Int; 2015 Jan; 35(1):240-53. PubMed ID: 24576072
[TBL] [Abstract][Full Text] [Related]
20. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
